CCIR faculty collaborate with: pharmacology, cancer biology, biomedical engineering, electrical engineering and material engineering, and physicians (including radiologists, surgeons, urologists and oncologists).
Our Mission
To catalyze and promote revolutionary biomedical imaging innovations that solve clinical and research problems by nurturing our collaborative research ecosystem.
Our Vision
To lead the next generation of transformative imaging research that will radically improve disease prevention, diagnosis, and therapy.
Our Scope
To be an integrated hub for biomedical imaging research and translation, providing strategic leadership and connecting multidisciplinary and diverse faculty and trainees.
Our Long-term Goal
To improve patient outcomes through
- Developing accessible and affordable diagnostic imaging technology and image-guided therapies
- Integrating imaging approaches across modalities and scales
- Establishing new paradigms that address disease prevention
Case Western Reserve University has a rich history of pioneering imaging research and translating our discoveries into clinical applications that are revolutionizing patient care. From the first CT-guided biopsies to innovative targeted imaging agents and entirely new imaging paradigms, imaging research at CWRU in collaboration with our clinical affiliates has led to many “firsts” in the field. These innovations are constantly improving patient care by making diagnoses and/or treatments newly possible, more accurate, more comfortable, safer, or less expensive. Our faculty are experts in their fields, making a critical impact in cancer, cardiovascular health, and neurology, as well as rare diseases, ophthalmology, and other areas.
Top strengths include, 1) imaging agents and theranostics; 2) new imaging technologies; and 3) imaging AI. Since 2005, the CWRU Center for Imaging Research has been a nucleus for imaging research and has helped foster numerous collaborations and successful grant proposals, moving discoveries from basic research through clinical trials to translational technologies.